· On April 10, 2022, first subject enrolled in phase 1 study accomplished in Shandong Provincial Qianfoshan Hospital. · On May 13, 2022, the second Clinical Trial Approval is obtained, for post-exposure prophylaxis in close contacts of individual...
Methods: In this phase 2-3, double-blind, randomized, placebo-controlled trial, we assigned patients who had mild-to-moderate coronavirus disease 2019 (Covid-19) and onset of symptoms within the past 3 days in a 1:1 ratio to ... B Cao,Y Wang,H Lu,... - 《New England Journal of...
· On April 10, 2022, first subject enrolled in phase 1 study accomplished in Shandong Provincial Qianfoshan Hospital. · On May 13, 2022, the second Clinical Trial Approval is obtained, for post-exposure prophylaxis in close contacts of individuals w...